Drug Delivery Research Unit (2DRU), School of Pharmacy, Faculty of Medical and Health Sciences and.
Pharm Dev Technol. 2014 Mar;19(2):238-46. doi: 10.3109/10837450.2013.769570. Epub 2013 Feb 25.
The aim of this study was to investigate the permeability of unique dispersion systems prepared by supercritical fluid (SCF) processing, to deliver bioidentical progesterone (PGN) across mouse skin. Semisolid dispersions of PGN were made up of either polyethylene glycol (PEG) 400/4000, Gelucire 44/14, d-α-tocopheryl PEG 1000 succinate (TPGS), tanscutol P or myritol 318. SCF dispersion systems were compared with various control formulations; a market cream, aqueous suspension, and three conventionally prepared dispersions comelted, cosolvent and physically mixed systems. The permeability coefficient in the absence or presence of a permeation enhancer was evaluated using ex vivo mouse skin. The permeation study results for the TPGS/myritol/transcutol P dispersion system prepared using supercritical carbon dioxide (SC-CO2) had a two-fold improvement in transdermal permeation over 24 h compared to the control formulation, 245.7 and 126 µg cm(-2), respectively (p value < 0.05). In this study, the skin integrity and morphology was also investigated for changes due to the formulation constituents using histological examination and Fourier transform infrared spectroscopy. The particles from the gas-saturated suspension method and SC-CO2 together with TPGS/myritol/transcutol P may offer potential advantages over the available cream on the market based on the vastly improved lag time and flux of PGN across the skin.
本研究旨在探讨通过超临界流体(SCF)处理制备的独特分散系统的渗透性,以将生物等同孕酮(PGN)递送至小鼠皮肤。PGN 的半固体分散体由聚乙二醇(PEG)400/4000、Gelucire 44/14、d-α-生育酚聚乙二醇 1000 琥珀酸酯(TPGS)、坦西妥尔 P 或 myritol 318 组成。SCF 分散系统与各种对照制剂进行了比较;市售乳膏、水性混悬液和三种常规制备的分散体-熔融、共溶剂和物理混合系统。使用离体小鼠皮肤评估不存在或存在渗透增强剂时的渗透系数。与对照制剂相比,使用超临界二氧化碳(SC-CO2)制备的 TPGS/myritol/transcutol P 分散系统的透皮渗透研究结果在 24 小时内提高了两倍,分别为 245.7 和 126µg·cm-2(p 值<0.05)。在这项研究中,还使用组织学检查和傅里叶变换红外光谱法研究了由于制剂成分导致的皮肤完整性和形态学变化。来自气体饱和悬浮法和 SC-CO2 与 TPGS/myritol/transcutol P 的颗粒可能比市场上现有的乳膏具有潜在优势,因为它们大大延长了 PGN 穿过皮肤的滞后时间和通量。